We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
MT-ND6 is not prognostic in Testicular Germ Cell Tumor (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
2448.6
Number of samples
133
Samples
Sample
Description
TPM
TCGA-ZM-AA06-01A
0 years, male, white, stage:Stage IB, alive, 1498 days
22149.4
TCGA-ZM-AA0E-01A
0 years, male, white, stage:Stage IA, alive, 811 days
12125.4
TCGA-XE-AAOL-01A
0 years, male, black or african american, stage:Stage I, alive, 13 days
11780.0
TCGA-XE-AAO6-01A
0 years, male, white, stage:Stage IA, alive, 240 days
10529.5
TCGA-ZM-AA0H-01A
0 years, male, white, stage:Stage IS, alive, 1736 days
8786.5
TCGA-2G-AAG6-01A
0 years, male, white, stage:Stage IS, alive, 2231 days
8087.3
TCGA-ZM-AA0F-01A
0 years, male, white, stage:Stage IA, alive, 681 days
7784.5
TCGA-ZM-AA05-01A
0 years, male, white, stage:Stage IIC, alive, 1126 days
6954.3
TCGA-ZM-AA0N-01A
0 years, male, white, stage:Stage IB, alive, 634 days
6758.1
TCGA-XE-AAO4-01A
0 years, male, white, stage:Stage IA, alive, 367 days
5836.2
TCGA-ZM-AA0D-01A
0 years, male, white, stage:Stage IA, alive, 848 days
5785.6
TCGA-2G-AAHG-01A
0 years, male, white, stage:Stage I, alive, 1819 days
5623.1
TCGA-YU-A90S-01A
0 years, male, white, stage:Stage IA, alive, 971 days
5464.1
TCGA-VF-A8AB-01A
0 years, male, black or african american, stage:Stage IA, alive, 760 days
4658.8
TCGA-ZM-AA0B-01A
0 years, male, white, stage:Stage IA, alive, 838 days
4476.1
TCGA-2G-AAGG-01A
0 years, male, white, stage:Stage IIIC, alive, 2611 days
4470.8
TCGA-XE-AAOC-01A
0 years, male, white, stage:Stage IA, alive, 270 days
4097.3
TCGA-XY-A89B-01A
0 years, male, white, stage:Stage IA, alive, 471 days
3916.2
TCGA-S6-A8JX-01A
0 years, male, white, stage:Stage IB, alive, 552 days
3853.8
TCGA-YU-A94I-01A
0 years, male, stage:Stage IA, alive, 536 days
3640.4
TCGA-WZ-A7V4-01A
0 years, male, white, stage:Stage I, alive, 894 days
3496.5
TCGA-2G-AAGV-01A
0 years, male, white, stage:'--, alive, 4527 days
3440.8
TCGA-WZ-A7V5-01A
0 years, male, white, stage:Stage I, alive, 1061 days
3259.8
TCGA-S6-A8JY-01A
0 years, male, white, stage:Stage IS, alive, 278 days
3192.0
TCGA-2G-AAGY-01A
0 years, male, white, stage:Stage IS, alive, 5329 days
3041.2
TCGA-YU-A912-01A
0 years, male, black or african american, stage:Stage IIIC, alive, 866 days
2906.4
TCGA-YU-A90Y-01A
0 years, male, black or african american, stage:Stage IIIC, dead, 17 days
2901.0
TCGA-XE-AAOD-01A
0 years, male, white, stage:Stage IB, alive, 2058 days
2758.0
TCGA-YU-A90Q-01A
0 years, male, stage:Stage IB, alive, 1964 days
2642.5
TCGA-2G-AAGZ-01A
0 years, male, white, stage:Stage IIIA, alive, 5233 days
2631.8
TCGA-2G-AAH2-01A
0 years, male, white, stage:Stage IS, alive, 6060 days
2577.6
TCGA-YU-AA61-01A
0 years, male, white, stage:Stage IS, alive, 864 days
2563.2
TCGA-2G-AAKM-01A
0 years, male, white, stage:Stage II, dead, 6972 days
2547.7
TCGA-XE-AANI-01A
0 years, male, white, stage:Stage IS, alive, 1041 days
2542.1
TCGA-2G-AAFJ-01A
0 years, male, asian, stage:'--, alive, 792 days
2538.7
TCGA-2G-AAH3-01A
0 years, male, white, stage:Stage I, alive, 1822 days
2535.7
TCGA-XE-AANV-01A
0 years, male, stage:Stage IB, alive, 1701 days
2509.7
TCGA-2G-AAFE-01A
0 years, male, white, stage:Stage IIA, alive, 4702 days
2493.4
TCGA-2G-AAG9-01A
0 years, male, white, stage:Stage IIIB, alive, 2234 days
2453.7
TCGA-2G-AAGP-01A
0 years, male, white, stage:Stage IIA, alive, 4018 days
2422.3
TCGA-2G-AAKG-01A
0 years, male, white, stage:Stage I, alive, 6598 days
2393.7
TCGA-XE-AAOF-01A
0 years, male, asian, stage:Stage IA, alive, 1268 days
2333.8
TCGA-YU-A90W-01A
0 years, male, white, stage:Stage IA, alive, 1113 days
2305.7
TCGA-2G-AAG3-01A
0 years, male, white, stage:Stage IS, alive, 1593 days
2303.2
TCGA-XE-AAOB-01A
0 years, male, white, stage:Stage IS, dead, 513 days
2249.6
TCGA-YU-A90P-01A
0 years, male, white, stage:Stage IA, alive, 2069 days
2216.6
TCGA-XE-A9SE-01A
0 years, male, white, stage:Stage IA, alive, 708 days
2216.6
TCGA-2G-AAG5-01A
0 years, male, white, stage:Stage IS, alive, 2299 days
2202.4
TCGA-VF-A8AE-01A
0 years, male, white, stage:Stage IA, alive, 727 days
2155.7
TCGA-2G-AAHN-01A
0 years, male, white, stage:Stage I, alive, 6445 days
2151.1
TCGA-2X-A9D5-01A
0 years, male, white, stage:Stage I, alive, 435 days
2139.7
TCGA-WZ-A8D5-01A
0 years, male, white, stage:'--, alive, 774 days
2128.7
TCGA-2G-AAGM-01A
0 years, male, white, stage:Stage IS, alive, 3891 days
2069.8
TCGA-4K-AA1I-01A
0 years, male, white, stage:Stage IA, alive, 3 days
2057.9
TCGA-WZ-A7V3-01A
0 years, male, white, stage:Stage I, alive, 753 days
2016.0
TCGA-XE-AANJ-01A
0 years, male, white, stage:Stage IS, alive, 2007 days
1999.4
TCGA-SN-A84W-01A
0 years, male, white, stage:Stage IS, alive, 293 days
1955.7
TCGA-2G-AAFV-01A
0 years, male, white, stage:Stage IS, alive, 1389 days
1949.3
TCGA-SN-A6IS-01A
0 years, male, white, stage:Stage IS, alive, 496 days
1922.0
TCGA-2G-AAGC-01A
0 years, male, white, stage:Stage IS, alive, 2585 days
1919.6
TCGA-VF-A8A9-01A
0 years, male, white, stage:Stage IA, alive, 1119 days
1867.6
TCGA-2X-A9D6-01A
0 years, male, white, stage:Stage I, alive, 607 days
1866.3
TCGA-XE-A8H4-01A
0 years, male, white, stage:Stage IA, alive, 559 days
1814.7
TCGA-2G-AAH0-01A
0 years, male, white, stage:Stage IS, alive, 5477 days
1794.2
TCGA-YU-A94D-01A
0 years, male, stage:Stage IIIB, alive, 2167 days
1777.4
TCGA-2G-AAF4-01A
0 years, male, white, stage:Stage I, alive, 2315 days
1768.8
TCGA-2G-AAHA-01A
0 years, male, white, stage:Stage IB, alive, 3349 days
1756.2
TCGA-2G-AAGO-01A
0 years, male, white, stage:Stage IS, alive, 4026 days
1743.4
TCGA-2G-AAL7-01A
0 years, male, white, stage:Stage IS, alive, 3991 days
1736.4
TCGA-2G-AAF8-01A
0 years, male, white, stage:Stage IA, alive, 3911 days
1606.4
TCGA-W4-A7U4-01A
0 years, male, white, stage:'--, alive, 738 days
1576.9
TCGA-VF-A8AA-01A
0 years, male, white, stage:Stage I, alive, 1146 days
1567.0
TCGA-SN-A84X-01A
0 years, male, white, stage:Stage IS, alive, 312 days
1562.7
TCGA-YU-AA4L-01A
0 years, male, black or african american, stage:Stage IIIC, alive, 1573 days
1553.9
TCGA-2G-AAG0-01A
0 years, male, white, stage:Stage IS, alive, 1529 days
1546.0
TCGA-2G-AAGT-01A
0 years, male, white, stage:Stage IS, alive, 4406 days
1498.7
TCGA-S6-A8JW-01A
0 years, male, white, stage:Stage IS, alive, 698 days
1481.6
TCGA-2G-AAHC-01A
0 years, male, white, stage:Stage IS, alive, 5539 days
1472.1
TCGA-2G-AAG7-01A
0 years, male, white, stage:Stage IS, alive, 2475 days
1459.4
TCGA-SB-A76C-01A
0 years, male, white, stage:'--, alive, 42 days
1428.4
TCGA-2G-AAL5-01A
0 years, male, white, stage:Stage I, alive, 7437 days
1414.7
TCGA-XE-AAOJ-01A
0 years, male, white, stage:Stage IS, alive, 1550 days
1358.8
TCGA-W4-A7U3-01A
0 years, male, white, stage:'--, alive, 149 days
1312.5
TCGA-2G-AAGE-01A
0 years, male, white, stage:Stage IS, alive, 2478 days
1273.4
TCGA-XE-A8H1-01A
0 years, male, white, stage:Stage IS, alive, 209 days
1248.7
TCGA-SB-A6J6-01A
0 years, male, white, stage:Stage IA, alive, 413 days
1247.9
TCGA-2G-AAGS-01A
0 years, male, white, stage:Stage IIIB, alive, 4816 days
1245.9
TCGA-2G-AAGX-01A
0 years, male, white, stage:Stage IA, alive, 5514 days
1182.4
TCGA-4K-AA1H-01A
0 years, male, white, stage:Stage IA, alive, 518 days
1169.7
TCGA-XY-A9T9-01A
0 years, male, white, stage:Stage IS, alive, 281 days
1161.1
TCGA-2G-AAFG-01A
0 years, male, white, stage:Stage IS, alive, 6183 days
1150.2
TCGA-2G-AAGI-01A
0 years, male, white, stage:Stage IS, alive, 3137 days
1136.8
TCGA-2G-AAH4-01A
0 years, male, white, stage:Stage II, alive, 6210 days
1114.9
TCGA-2G-AAFH-01A
0 years, male, white, stage:Stage IIB, alive, 1375 days
1114.5
TCGA-2G-AAKH-01A
0 years, male, white, stage:Stage II, alive, 6862 days
1112.8
TCGA-2G-AALP-01A
0 years, male, white, stage:Stage IIIB, alive, 2645 days
1059.7
TCGA-2G-AAHL-01A
0 years, male, white, stage:Stage I, alive, 7081 days
1048.5
TCGA-2G-AAGA-01A
0 years, male, white, stage:Stage IIA, alive, 2439 days
1041.8
TCGA-2G-AAF1-01A
0 years, male, asian, stage:Stage IS, alive, 1403 days
1039.6
TCGA-4K-AAAL-01A
0 years, male, white, stage:Stage IS, alive, 483 days
1032.9
TCGA-SO-A8JP-01A
0 years, male, white, stage:Stage I, alive, 540 days
1028.8
TCGA-XY-A8S2-01A
0 years, male, white, stage:Stage I, alive, 672 days
1028.2
TCGA-2G-AAFL-01A
0 years, male, white, stage:Stage IB, alive, 750 days
982.4
TCGA-2G-AAFM-01A
0 years, male, white, stage:Stage IIA, alive, 503 days
952.3
TCGA-2G-AAFY-01A
0 years, male, white, stage:Stage IIA, alive, 1099 days
930.6
TCGA-2G-AAG8-01A
0 years, male, white, stage:Stage IB, alive, 2289 days
919.9
TCGA-2G-AAFI-01A
0 years, male, white, stage:Stage IB, alive, 675 days
918.0
TCGA-XE-AAO3-01A
0 years, male, asian, stage:Stage I, alive, 2857 days
908.9
TCGA-XE-AANR-01A
0 years, male, white, stage:Stage I, alive, 14 days
892.6
TCGA-2G-AAKL-01A
0 years, male, white, stage:Stage II, alive, 7023 days
890.7
TCGA-2G-AAEW-01A
0 years, male, white, stage:Stage IS, dead, 618 days
886.3
TCGA-2G-AAH8-01A
0 years, male, white, stage:Stage IIIC, alive, 2248 days
872.6
TCGA-2G-AAGN-01A
0 years, male, white, stage:Stage IIIB, alive, 3656 days
872.3
TCGA-W4-A7U2-01A
0 years, male, white, stage:'--, alive, 1263 days
867.3
TCGA-SN-A84Y-01A
0 years, male, white, stage:Stage IS, alive, 524 days
858.7
TCGA-VF-A8AD-01A
0 years, male, white, stage:Stage IB, alive, 1006 days
829.3
TCGA-2G-AAGK-01A
0 years, male, white, stage:Stage IS, alive, 3621 days
808.9
TCGA-2G-AAFO-01A
0 years, male, white, stage:Stage IIA, alive, 685 days
781.8
TCGA-VF-A8AC-01A
0 years, male, white, stage:Stage IA, alive, 1083 days
770.2
TCGA-XE-A8H5-01A
0 years, male, stage:Stage IS, alive, 1217 days
707.1
TCGA-2G-AAF6-01A
0 years, male, white, stage:Stage IS, alive, 3491 days
682.8
TCGA-2G-AAHT-01A
0 years, male, white, stage:Stage IS, alive, 542 days
656.4
TCGA-2G-AAFN-01A
0 years, male, white, stage:Stage IIIB, alive, 773 days
652.8
TCGA-2G-AAGW-01A
0 years, male, white, stage:Stage IS, alive, 4899 days
627.4
TCGA-2G-AAEX-01A
0 years, male, white, stage:Stage IS, alive, 1259 days
608.6
TCGA-2G-AAGJ-01A
0 years, male, black or african american, stage:Stage IA, alive, 2938 days
603.4
TCGA-X3-A8G4-01A
0 years, male, white, stage:Stage IS, alive, 856 days
594.3
TCGA-VF-A8A8-01A
0 years, male, white, stage:Stage IA, alive, 1131 days
564.1
TCGA-2G-AAFZ-01A
0 years, male, white, stage:Stage III, alive, 1353 days
503.2
TCGA-2G-AAGF-01A
0 years, male, white, stage:Stage IS, alive, 2734 days
473.8
TCGA-2G-AAKD-01A
0 years, male, white, stage:Stage III, alive, 6340 days
357.0
TCGA-4K-AA1G-01A
0 years, male, white, stage:Stage IS, alive, 436 days
291.2
TCGA-2G-AAHP-01A
0 years, male, white, stage:Stage IS, alive, 5667 days
91.6
Show allShow less
TESTIS CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.